PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A 12-week double-blind, placebo-controlled study showed a 22% reduction in axillary hair growth with C. aeruginosa extract [PMID:29428960]. Another trial using 1% or 5% essential oil lotion demonstrated it is an efficacious inhibitor of axillary hair growth [PMID:28190468].
The plant is cited as having evidence-based effects against alopecia [PMID:31680216] and can improve the cutaneous penetration of minoxidil [PMID:29159692].
C. aeruginosa is associated with antioxidant and anti-inflammatory activities in the skin, potentially benefiting wound healing and preventing chronic UVB damage [PMID:33522006].
Methanolic extracts showed antifungal activity with a minimum inhibitory concentration (MIC) of 3.8 mg/mL [PMID:36224024].
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 26092132 (2015) — Antinociceptive principle from Curcuma aeruginosa. · BMC complementary and alternative medicine
- 2.PMID: 33522006 (2021) — Dermatological effects of Curcuma species: a systematic review. · Clinical and experimental dermatology
- 3.PMID: 31680216 (2020) — Herbal preparations for the treatment of hair loss. · Archives of dermatological research
- 4.PMID: 37383824 (2023) — Dataset of de novo transcriptome assembly of Rhizome in Curcuma aeruginosa Roxb. · Data in brief
- 5.PMID: 39056691 (2024) — Network Pharmacology Reveals Curcuma aeruginosa Roxb. Regulates MAPK and HIF-1 Pathways to Treat Androgenetic Alopecia.